Last Call: Goodbye at 11.59pm Today
Here is the latest financial fact sheet of AARTI DRUGS. For more details, see the AARTI DRUGS quarterly results and AARTI DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.6 |
No. of shares | m | 91.94 |
1 Week | % | -4.5 |
1 Month | % | 2.2 |
1 Year | % | 21.8 |
52 week H/L | Rs | 645.0/310.8 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
AARTI DRUGS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 705 | 813 | 3,725 | 841 | 532 | |
Low | Rs | 500 | 419 | 506 | 419 | 311 | |
Sales per share (Unadj.) | Rs | 662.0 | 775.1 | 231.2 | 268.8 | 293.3 | |
Earnings per share (Unadj.) | Rs | 38.1 | 60.7 | 30.1 | 22.1 | 18.0 | |
Diluted earnings per share | Rs | 9.8 | 15.4 | 30.5 | 22.3 | 18.1 | |
Cash flow per share (Unadj.) | Rs | 56.1 | 81.6 | 35.4 | 27.5 | 23.4 | |
Dividends per share (Unadj.) | Rs | 1.00 | 2.00 | 2.50 | 1.00 | 1.00 | |
Adj. dividends per share | Rs | 0.26 | 0.51 | 2.53 | 1.01 | 1.01 | |
Avg Dividend yield | % | 0.2 | 0.3 | 0.1 | 0.2 | 0.2 | |
Book value per share (Unadj.) | Rs | 230.5 | 280.0 | 98.0 | 111.9 | 128.8 | |
Adj. book value per share | Rs | 59.1 | 71.0 | 99.4 | 112.7 | 129.7 | |
Shares outstanding (eoy) | m | 23.58 | 23.30 | 93.20 | 92.60 | 92.60 | |
Price / Sales ratio | x | 0.9 | 0.8 | 9.1 | 2.3 | 1.4 | |
Avg P/E ratio | x | 15.8 | 10.2 | 70.3 | 28.5 | 23.4 | |
P/CF ratio (eoy) | x | 10.7 | 7.5 | 59.7 | 22.9 | 18.0 | |
Price / Book Value ratio | x | 2.6 | 2.2 | 21.6 | 5.6 | 3.3 | |
Dividend payout | % | 2.6 | 3.3 | 8.3 | 4.5 | 5.6 | |
Avg Mkt Cap | Rs m | 14,208 | 14,352 | 197,132 | 58,333 | 39,003 | |
Total wages/salary | Rs m | 546 | 613 | 659 | 693 | 804 |
AARTI DRUGS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 15,609 | 18,061 | 21,548 | 24,886 | 27,161 | |
Other income | Rs m | 24 | 15 | 45 | 113 | 22 | |
Total revenues | Rs m | 15,634 | 18,076 | 21,593 | 25,000 | 27,182 | |
Gross profit | Rs m | 2,147 | 2,700 | 4,406 | 3,326 | 3,095 | |
Depreciation | Rs m | 426 | 488 | 499 | 500 | 503 | |
Interest | Rs m | 435 | 374 | 262 | 239 | 371 | |
Profit before tax | Rs m | 1,310 | 1,853 | 3,690 | 2,700 | 2,242 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 413 | 439 | 886 | 650 | 578 | |
Profit after tax | Rs m | 898 | 1,414 | 2,804 | 2,050 | 1,664 | |
Gross profit margin | % | 13.8 | 14.9 | 20.4 | 13.4 | 11.4 | |
Effective tax rate | % | 31.5 | 23.7 | 24.0 | 24.1 | 25.8 | |
Net profit margin | % | 5.7 | 7.8 | 13.0 | 8.2 | 6.1 |
AARTI DRUGS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 7,843 | 9,040 | 10,568 | 13,934 | 14,923 | |
Current liabilities | Rs m | 5,910 | 6,232 | 5,954 | 9,401 | 9,330 | |
Net working cap to sales | % | 12.4 | 15.5 | 21.4 | 18.2 | 20.6 | |
Current ratio | x | 1.3 | 1.5 | 1.8 | 1.5 | 1.6 | |
Inventory Days | Days | 3 | 3 | 4 | 7 | 6 | |
Debtors Days | Days | 1,072 | 988 | 941 | 1,100 | 1,162 | |
Net fixed assets | Rs m | 6,712 | 6,725 | 7,092 | 8,146 | 9,290 | |
Share capital | Rs m | 236 | 233 | 932 | 926 | 926 | |
"Free" reserves | Rs m | 5,199 | 6,292 | 8,202 | 9,438 | 10,998 | |
Net worth | Rs m | 5,434 | 6,525 | 9,134 | 10,364 | 11,924 | |
Long term debt | Rs m | 2,082 | 1,803 | 1,476 | 1,385 | 2,047 | |
Total assets | Rs m | 14,555 | 15,765 | 17,660 | 22,080 | 24,214 | |
Interest coverage | x | 4.0 | 6.0 | 15.1 | 12.3 | 7.0 | |
Debt to equity ratio | x | 0.4 | 0.3 | 0.2 | 0.1 | 0.2 | |
Sales to assets ratio | x | 1.1 | 1.1 | 1.2 | 1.1 | 1.1 | |
Return on assets | % | 9.2 | 11.3 | 17.4 | 10.4 | 8.4 | |
Return on equity | % | 16.5 | 21.7 | 30.7 | 19.8 | 14.0 | |
Return on capital | % | 23.2 | 26.7 | 37.3 | 25.0 | 18.7 | |
Exports to sales | % | 32.2 | 28.3 | 27.9 | 30.4 | 31.4 | |
Imports to sales | % | 33.3 | 35.0 | 34.9 | 34.6 | 33.4 | |
Exports (fob) | Rs m | 5,022 | 5,106 | 6,008 | 7,563 | 8,536 | |
Imports (cif) | Rs m | 5,204 | 6,323 | 7,524 | 8,612 | 9,082 | |
Fx inflow | Rs m | 5,022 | 5,106 | 6,008 | 7,563 | 8,536 | |
Fx outflow | Rs m | 5,388 | 6,501 | 7,701 | 8,742 | 9,352 | |
Net fx | Rs m | -366 | -1,395 | -1,693 | -1,179 | -816 |
AARTI DRUGS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,431 | 2,507 | 1,550 | 704 | 1,342 | |
From Investments | Rs m | -617 | -332 | -718 | -1,496 | -1,640 | |
From Financial Activity | Rs m | -801 | -2,154 | -811 | 920 | 165 | |
Net Cashflow | Rs m | 14 | 21 | 20 | 128 | -132 |
Share Holding
Shareholding as on Jun 2023
|
Company Information
|
CHM: Prakash M Patil | COMP SEC: Rushikesh Deole | YEAR OF INC: 1984 | BSE CODE: 524348 | FV (Rs): 10 | DIV YIELD (%): 0.2 |
Read: AARTI DRUGS 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN DR. REDDYS LAB
Compare AARTI DRUGS With: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN DR. REDDYS LAB
After opening the day on a positive note, Indian share markets continued the momentum as the session progressed and ended the day higher.